Bodily Distress Disorder (ICD-11): Symptoms, Criteria, and Treatment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Bodily distress disorder (BDD) is a diagnosis in the World Health Organization's International Classification of Diseases, Eleventh Revision (ICD-11), code 6C20. It describes a persistent pattern of distressing bodily symptoms accompanied by excessive attention directed toward those symptoms and meaningful interference with daily functioning. Diagnosis depends on the full clinical pattern, appropriate medical assessment, and consideration of other disorders. Symptoms may coexist with an established physical disease. The primary clinical authority is the WHO ICD-11 Clinical Descriptions and Diagnostic Requirements.
People experiencing bodily distress may have pain, fatigue, nausea, dizziness, gastrointestinal symptoms, palpitations, or other uncomfortable sensations. Such symptoms are real experiences and can arise in many different medical circumstances. Bodily distress disorder is the name of a defined clinical condition, not an automatic description of everyone with persistent symptoms. A symptom's intensity, unexplained status, or the number of appointments a patient requests is never sufficient by itself to establish the diagnosis.
What is bodily distress disorder in ICD-11?
ICD-11 bodily distress disorder involves bodily symptoms experienced as distressing and an excessive amount of attention devoted to those symptoms. This attention may manifest in persistent preoccupation and repeated engagement with healthcare, but it must be interpreted in context. The symptomatic pattern extends across several months and is associated with significant interference in important areas of life. WHO recognizes mild, moderate, and severe presentations.
The diagnosis reflects an important change from ICD-10's older somatoform-disorder categories. Earlier classifications frequently relied on whether physical symptoms could be medically explained. That approach was difficult to apply consistently, particularly when investigations were incomplete, more than one condition existed, or scientific understanding changed. ICD-11 instead emphasizes affirmative clinical features, including the nature of attention, distress, duration, and impairment. The history and rationale are discussed in the WHO classification review and Gureje and Reed's analysis of the proposed disorder.
BDD is included in the ICD-11 grouping Disorders of Bodily Distress or Bodily Experience, together with distinct conditions such as body integrity dysphoria. It is separate from body dysmorphic disorder, which concerns perceived appearance defects. It should also be distinguished from bodily distress syndrome, an independently developed research construct with different operational definitions. Similar names do not mean these diagnoses have identical criteria.
Symptoms and signs: what can bodily distress disorder feel like?
Bodily complaints vary considerably. Pain may affect the head, chest, abdomen, back, muscles, or several parts of the body. Other reported problems include fatigue, weakness, nausea, altered bowel habits, bloating, dizziness, shortness of breath, rapid heartbeat, or uncomfortable sensory changes. Symptoms may fluctuate from day to day, change locations, or remain centered on one principal complaint. A single prominent symptom, such as pain or fatigue, may occur.
What distinguishes the ICD-11 disorder is the associated clinical pattern of excessive symptom-focused attention and functional impact. A person may spend considerable time monitoring sensations, fearing a symptom's meaning, repeatedly seeking reassurance, or modifying activities in response to symptoms. These are examples of possible presentations, not individual diagnostic tests. Medical care-seeking can be appropriate, particularly when illness remains unrecognized, symptoms change, or previous encounters have not adequately addressed the complaint.
The lived consequences may include interrupted sleep, reduced school or work attendance, restricted social life, changes in family responsibilities, and difficulty concentrating on activities beyond physical discomfort. The clinician must examine both the symptom burden and the person's circumstances. Someone with severe medical illness may reasonably devote extensive attention to treatment; disability and barriers to healthcare can further complicate the interpretation of behavior.
There is no single characteristic sensation, laboratory marker, questionnaire score, or visible appearance that establishes BDD. The same headache, abdominal pain, or fatigue can occur in several medical or mental health conditions. The clinical task is to understand why the symptom is occurring where possible, how the person is responding, and which diagnoses actually meet their requirements.
ICD-11 diagnostic requirements
Distressing bodily symptoms
The patient experiences one or more bodily symptoms as distressing. ICD-11 does not demand a particular number of body systems, a rigid pain distribution, or a fixed list of sensations. Clinical documentation should identify onset, duration, intensity, triggers, variation, accompanying features, relevant physical findings, and the effects of existing treatments.
A medically diagnosed condition may contribute to the symptoms. The presence of such illness does not automatically exclude BDD, but the clinician must establish that the additional symptom-focused attention is clearly excessive in relation to the medical condition's nature and severity. This contextual requirement is especially important in complex chronic disease, where symptom monitoring and repeated appointments may be medically justified.
Excessive attention directed toward symptoms
Excessive attention is central to the ICD-11 model. Persistent preoccupation, continued focus on sensations, and disproportionate time and energy spent on the symptoms may contribute to this criterion. In the classification description, repeated contacts with health professionals may be one manifestation; persistence despite appropriate examination, investigation, and reassurance may also be relevant.
The criterion requires professional interpretation. Repeated consultations after diagnostic delay, disputed test results, inaccessible specialist care, or genuinely changing symptoms may be entirely reasonable. A patient's insistence that symptoms deserve consideration is not evidence of psychiatric disorder. Healthcare inequities, previous dismissal, serious underlying disease, and realistic uncertainty all need explicit consideration.
Persistence over several months
BDD involves a sustained pattern rather than a brief reaction to new symptoms. The ICD-11 wording refers to symptoms and associated preoccupation persisting for several months, for example three months or more. The 2025 multinational comparative study contrasts this with the DSM-5 description of somatic symptom disorder as typically continuing longer than six months.
Duration is necessary but insufficient. A persistent illness may need repeated medical investigation or long-term treatment. Conversely, intense but short-lived illness-related worry is not automatically BDD. A new symptom, even in someone with longstanding BDD, needs its own clinical assessment.
Distress and impairment
Symptoms and their associated preoccupation must be linked with significant impairment in personal, family, social, educational, occupational, or other important functioning. Clinicians look at what the person can do, how responsibilities have changed, the effect on relationships and participation, and whether assistance is needed to manage daily life.
A person's functional limits should be understood on their own terms. Objective medical disability, limited workplace accommodations, financial strain, inaccessible transport, and gaps in treatment can produce or intensify impairment. Accurate diagnosis requires identifying these circumstances, not automatically attributing every difficulty to an excessive psychological response.
Differential diagnosis
The symptoms and their associated distress or preoccupation should not be better explained by another mental disorder, and medical diagnoses require appropriate assessment. Some conditions can coexist. Clinicians consider symptom-specific causes, common psychiatric comorbidities, medication effects, and the longitudinal course rather than applying the label to unexplained symptoms alone.
These subsections explain major elements of the WHO CDDR in accessible language. They are a guide to understanding the professional classification, not a substitute for using the official requirements in clinical practice.
ICD-11 codes and severity specifiers
The parent code is 6C20. The subcodes are 6C20.0 for mild bodily distress disorder, 6C20.1 for moderate bodily distress disorder, 6C20.2 for severe bodily distress disorder, and 6C20.Z for unspecified bodily distress disorder. These belong to the WHO's ICD-11 classification.
Clinical severity reflects the extent and persistence of symptoms and preoccupation and their impact on functioning. It is assessed through the whole presentation, not by counting the number of painful body sites or assigning a score based on healthcare visits. Mild BDD can involve genuine suffering; severe BDD does not indicate intentional exaggeration or an inevitably poor prognosis.
Countries transition to ICD-11 at different rates. International codes may differ from the codes required for local insurance or electronic clinical records. Coding practices should follow the national system actually in use.
Can bodily distress disorder coexist with physical illness?
Yes. ICD-11 permits BDD when a medical condition causes or contributes to symptoms, provided that the symptom-focused attention is clearly excessive in relation to the nature and severity of the medical condition and that the remaining requirements are satisfied. A person can need medical treatment and psychologically informed care at the same time.
For example, someone living with a recognized chronic disease could also experience severe preoccupation, extensive symptom monitoring, and daily-life restriction beyond what their illness and circumstances reasonably explain. A clinician may consider BDD after a careful individualized assessment. Another person with similar behavior might have uncontrolled disease, an overlooked complication, adverse drug effects, inadequate support, or a realistic need for additional tests. These possibilities cannot be resolved by an online description.
Medical illness should continue to be investigated and treated when clinically indicated. The diagnosis must not become an administrative shortcut for discounting new physical findings. The 2025 World Mental Health study emphasizes that modern BDD and DSM somatic symptom disorder do not require symptoms to be medically unexplained.
Bodily distress disorder versus DSM-5-TR somatic symptom disorder
ICD-11 BDD and DSM-5-TR somatic symptom disorder (SSD) share important features, including distressing physical symptoms and excessive symptom-related psychological or behavioral responses. They remain distinct diagnostic constructs. The American Psychiatric Association's DSM-5-TR chapter and the WHO ICD-11 CDDR present their own diagnostic logic.
ICD-11 BDD centrally requires excessive attention directed toward bodily symptoms, associated impairment, and persistence for several months. DSM-5-TR SSD requires one or more distressing or disruptive bodily symptoms and at least one form of excessive related thoughts, feelings, or behavior. DSM-5-TR specifies a persistent symptomatic state typically longer than six months, while the ICD-11 description refers to several months. The ICD-11 exclusion when another mental disorder better accounts for the presentation also differs from the DSM formulation.
A 2025 World Psychiatry comparison of community surveys found that people meeting operational criteria for one classification did not necessarily meet those for the other. The differences matter when recording clinical diagnoses, comparing studies, interpreting prevalence, or translating medical documents across health systems.
Classification placement differs elsewhere too. ICD-11 hypochondriasis appears among obsessive-compulsive or related disorders, whereas DSM-5-TR illness anxiety disorder appears in the somatic symptom and related disorders grouping. The formal comparative classification analysis documents broader differences across these systems. A clinical crosswalk therefore requires reassessment of criteria rather than simple label substitution.
Bodily distress disorder versus bodily distress syndrome
Bodily distress syndrome (BDS) refers to a separate research construct describing particular clusters of persistent physical symptoms, associated especially with Scandinavian research. It is not the name of ICD-11 diagnosis 6C20. Studies recruiting under BDS criteria may have different participants from those meeting ICD-11 BDD requirements. The evidence cannot automatically be transported from one group to the other.
The terms persistent physical symptoms, functional somatic symptoms, medically unexplained symptoms, and somatization also have different historical and research uses. Some describe symptoms rather than a disorder. Others depend on outdated assumptions about the absence of medical explanation. Terminology should identify the definition being used and the clinical question being answered.
Conditions including irritable bowel syndrome, fibromyalgia, migraine, dysautonomia, and myalgic encephalomyelitis/chronic fatigue syndrome require their own condition-specific assessment. Their diagnosis does not establish BDD. Some people may meet criteria for two conditions, but such coexistence must be evaluated on its own merits.
BDD versus illness anxiety and hypochondriasis
Health anxiety refers broadly to worry or fear about illness. Concern during medical uncertainty is common and may be understandable. ICD-11 hypochondriasis is a distinct clinical category focused on persistent preoccupation with or fear of serious illness and associated repetitive health behavior or maladaptive avoidance. It is located in the ICD-11 obsessive-compulsive or related disorders grouping, as explained by the ICD–DSM comparison.
BDD centers on distressing bodily symptoms accompanied by excessive attention to them. Hypochondriasis emphasizes fear and preoccupation about having a serious disease. The distinction may be difficult when both symptoms and illness fears are prominent. A full evaluation considers the central concern, the symptom history, impairment, and the requirements for each disorder.
Panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, and depression can include bodily sensations, checking, or illness concerns. They may also coexist with a medical condition. The experience of bodily arousal alone does not identify the diagnosis. The Hub's published English article Anxiety and Interoception: Why Body Sensations Can Become Threat Signals examines one related dimension without substituting for clinical assessment.
BDD versus functional neurological disorder
Functional neurological disorder (FND) involves neurological symptom presentations assessed through an appropriate neurological examination and relevant positive clinical signs. The absence of a structural explanation is not by itself a positive diagnostic sign. Functional weakness, movement symptoms, or seizure-like episodes require condition-specific neurological assessment, and FND may coexist with neurological disease.
BDD concerns excessive attention to distressing bodily symptoms across a persistent clinical course. FND is organized around particular neurological functional symptoms and their diagnostic characteristics. Some individuals may have both forms of difficulty; others have one or neither. Neither diagnosis implies that a person is pretending to be ill.
Historical discussions of conversion disorders belong to a different question. Readers can explore the site's existing English article Conversion Neurosis: Historical Meaning and Functional Neurological Symptom Disorder, while the modern classification should be interpreted using the relevant current neurological and psychiatric standards.
Differential diagnosis and common comorbidities
A responsible differential starts from the presenting symptoms. For fatigue, clinicians may consider sleep disorders, anemia, endocrine problems, medications, infection, post-viral conditions, and exertion-related symptom patterns. Abdominal symptoms may warrant consideration of gastrointestinal disease, medication effects, and gut–brain disorders. Pain can relate to inflammatory, neurological, musculoskeletal, or other medical conditions.
Palpitations or dizziness may require evaluation of cardiovascular disease, autonomic conditions, vestibular disorders, medication reactions, or anxiety-associated arousal. New weakness, speech changes, or altered awareness may require neurological assessment. Specific testing follows history, examination, age, risk, and red flags; there is no standard investigation panel that can prove or exclude every possible cause of persistent symptoms.
Clinicians also evaluate whether depression, panic, generalized anxiety, OCD, sleep disturbance, trauma-related disorders, or another psychiatric condition better explains associated preoccupation or contributes independently. Associations between emotional distress and physical symptoms do not establish a single universal cause. A traumatic event may be relevant to a person's history, but trauma is not a necessary cause or criterion of BDD.
Factitious disorder and malingering involve separate concepts and require evidence of intentionality; suspicion must never arise simply because a patient consults repeatedly or presents difficult-to-explain symptoms. A diagnosis of BDD does not mean a patient deliberately produces symptoms.
Clinical assessment: from symptoms to a shared formulation
Assessment should begin with a clear symptom narrative. The clinician asks when each main complaint started, how it changes, what has already been investigated, which treatments have helped or caused difficulties, and whether relevant medical findings have evolved. Reviewing previous records reduces duplication and can reveal patterns that are easy to miss during a single consultation.
A physical examination and targeted investigations address indications arising from the history. Normal findings for a particular test may be reassuring for the specific condition it assessed, but they do not establish BDD. The clinical reasoning should state which conditions have been considered, what remains uncertain, and which future changes require new evaluation.
The clinician then explores the attention and responses that accompany symptoms. Questions might cover time spent noticing sensations, searching for explanations, checking the body, seeking reassurance, avoiding activities, and worrying about deterioration. The aim is understanding, not testing whether the patient's symptoms are believed. Cultural background, previous care, realistic disease risks, and access problems shape the meaning of these behaviors.
Functional assessment documents sleep, daily activities, education, employment, family roles, and social participation. A shared formulation brings medical findings, psychological responses, personal history, strengths, practical obstacles, and treatment goals into one provisional account. This formulation is updated when new evidence arises.
Can a questionnaire diagnose BDD?
No. Instruments such as the Somatic Symptom Scale–8 or Patient Health Questionnaire–15 measure reported symptom burden in related settings. They are useful for tracking symptoms or research but do not replace an ICD-11 interview, medical evaluation, and consideration of functional impairment and differential diagnosis. A high score can reflect a documented physical disease or several other conditions.
Interpretation also depends on language, age, cultural setting, response patterns, and the chosen questionnaire. Tools adapted for DSM somatic symptom research should not be treated as fully validated stand-alone tests for ICD-11 6C20 unless separate evidence establishes that use.
How reliable is ICD-11 clinical identification?
In a 2023 WHO-linked field study, 1,065 clinicians evaluated standardized case vignettes using ICD-11 or ICD-10 guidance. ICD-11 diagnostic accuracy was higher for the bodily distress presentations tested, and clinicians generally applied the severity specifiers appropriately.
That study tested judgments about written cases under controlled conditions. It does not guarantee flawless assessment in real-world clinics, where medical uncertainty, complex multimorbidity, and evolving symptoms create additional challenges. Diagnostic clarity, follow-up, and transparent explanation remain important.
How common is bodily distress disorder?
One of the strongest population-level comparisons appeared in World Psychiatry in 2025. Surveys of 18,105 adults across Hong Kong, the Philippines, and Qatar found estimated point prevalences of 2.0% for operationalized ICD-11 BDD and 3.5% for DSM somatic symptom disorder. About 4.1% met criteria for at least one of these operational categories.
The samples showed differences across populations, associations with mental and physical health conditions, and meaningful role impairment. These are findings from three community survey settings using research implementations of diagnostic requirements, not a universal prevalence estimate for the world's population.
Estimates may change with interviewing methods, language, cultural practices, health system access, age, and how clinical criteria are operationalized. Importantly, prevalence of bodily symptoms in the general population cannot be substituted for prevalence of BDD.
What mechanisms may contribute to bodily distress?
The clinical experience of bodily distress reflects interactions among sensory and physiological activity, existing illness, sleep, attention, emotion, learning, expectations, and the person's social environment. There is no established single cause that applies to every patient. A diagnosis defined by clinical features does not by itself determine where an individual symptom originated.
Attention to the body is a possible maintaining factor. When bodily sensations are interpreted as highly threatening, a person may notice them more readily, experience additional arousal, and monitor them more closely. Repeated checking or reassurance may sometimes sustain the preoccupation. These mechanisms are relevant to cognitive behavioral models, but their role must be assessed individually. They do not provide laboratory proof of a psychological origin for every symptom.
Some researchers investigate interoception, predictive processing, stress-related physiology, and learning as explanatory frameworks. These are useful scientific models with varying levels of evidence and ongoing debate. BDD is not diagnosed through a unique brain scan, neurotransmitter profile, or biomarker.
A 2024 systematic review and meta-analysis evaluated psychological factors in 43 studies involving 3,760 patients with DSM somatic symptom disorder. Depression, anxiety, health anxiety, and difficulty identifying feelings were associated with the condition in the reviewed literature. The evidence set did not directly include patients recruited under final ICD-11 BDD criteria, so the findings inform broader understanding rather than proving BDD-specific causality.
Health systems and life circumstances also matter. Fragmented care, repeated invalidation, language barriers, insufficient workplace accommodations, and prolonged uncertainty can increase suffering. These experiences should be addressed as potentially modifiable contributors to health and access, not automatically recast as signs of excessive patient concern.
Treatment: managing symptoms, attention, and functioning
Treatment combines appropriate medical care with support for distress, symptom-related attention, everyday activities, and coexisting conditions. A good plan begins with an understandable explanation of why the ICD-11 diagnosis has been considered, what medical possibilities have been reviewed, how any coexisting illness will be treated, and what developments should prompt reassessment.
Evidence must be interpreted carefully. Many treatment trials studied ICD-10 somatoform disorders, medically unexplained physical symptoms, or DSM somatic symptom disorder. Direct randomized trial evidence restricted to people who meet final ICD-11 BDD requirements is more limited. Findings from related populations can guide care but should not be presented as precise BDD-specific effect sizes.
Coordinated medical care
Continuity with a trusted primary care clinician or coordinated clinical team helps make investigations, referrals, and treatment decisions coherent. Planned visits allow review of new findings, medications, functional goals, and responses to interventions. The patient should know whom to contact when symptoms evolve.
A useful clinical explanation validates the experience of symptoms, explains what examinations have established, acknowledges remaining uncertainty, and identifies symptom-related patterns that may be treatable. Medical testing remains available when indicated; the goal is rational evaluation rather than repetitive investigations without a clinical question.
Cognitive behavioral therapy
Cognitive behavioral therapy (CBT) is among the most studied psychological treatments for older somatoform and persistent-physical-symptom presentations. Sessions may address threatening interpretations, repeated body monitoring, avoidance, reassurance patterns, distress tolerance, and the gradual restoration of valued activities. Treatment should accommodate medically justified restrictions and personal priorities.
A Cochrane review of 21 randomized trials, with 2,658 participants in related older diagnostic populations, found modest improvements in symptom severity for psychological therapies compared with usual care or waiting lists. Evidence comparing therapy with enhanced medical care was less conclusive, and overall certainty was limited. CBT was the main sufficiently studied modality.
These results support considering psychotherapy as part of a broader care plan, while preserving diagnostic specificity. Participation in psychological care is not an admission that symptoms are fabricated. Psychological interventions can address suffering and functional consequences regardless of whether a medical illness also exists.
Rehabilitation and everyday activity
Occupational support, individualized rehabilitation, and adjustments to routines may help restore participation in activities that matter to the person. Suitable approaches depend on symptom pattern, physical diagnosis, current capacity, and risk. Interventions can include reasonable workplace accommodations, occupational therapy, rehabilitation consultation, or support for sleep and daily structure.
There is no proven universal exercise protocol for ICD-11 BDD. Some medical conditions, including those involving post-exertional symptom exacerbation, require disease-specific safeguards and can worsen with inappropriate graded activity. Activity recommendations should reflect the patient's diagnosis and response, not a generic instruction to push through all symptoms.
Medication and coexisting disorders
No medicine has been established as a specific cure for ICD-11 bodily distress disorder. Medication may be appropriate for separately diagnosed anxiety, depression, sleep disorders, pain conditions, or medical illness. Prescribing requires an individualized discussion of target symptoms, expected benefits, adverse effects, and interactions.
A Cochrane review of drug treatment in older somatoform disorders found limited and often low-certainty evidence for medication comparisons. These findings cannot be straightforwardly applied to all people with ICD-11 BDD. Prescribed medication should not be discontinued on the basis of an online diagnostic explanation.
Managing comorbid anxiety, depression, and pain
Coexisting psychiatric disorders and diagnosed medical conditions each deserve their own indicated treatment. Treating depression, improving sleep, managing pain, or addressing panic symptoms may support participation and reduce overall distress even when some bodily symptoms persist.
The 2023 review of somatic symptom disorder and health anxiety discusses evidence-based approaches in DSM-related clinical populations. Its practical principles can be relevant, but ICD-11 BDD deserves explicit recognition as a distinct classification rather than a presumed synonym.
Prognosis and recovery
Recovery can include reduced preoccupation, improved participation in relationships and work, more stable sleep, greater confidence in managing symptoms, fewer unnecessary medical crises, and a clearer plan for genuine medical changes. Not everyone achieves complete symptom resolution, and improvement in function is itself a meaningful outcome.
Some people experience recurring or persistent difficulties, especially when medical comorbidities, social hardship, ineffective treatment, or complex symptoms remain. The long-term prognosis of cohorts recruited specifically with final ICD-11 BDD criteria is less well established than the course of broader somatic symptom populations. This is an evidence gap rather than a justification for assuming poor outcomes.
Treatment review should attend to the person's own goals, functional change, symptom distress, and medical developments. If a plan does not help, clinicians should consider whether the diagnosis needs revision, whether important comorbidity or barriers were missed, and whether a different intervention would be more appropriate.
Children and adolescents
Physical symptoms can disrupt a young person's school attendance, friendships, sleep, family life, and independence. Children may communicate distress differently at different developmental stages; caregivers and schools shape access to treatment and everyday functioning. Pediatric evaluation should account for growth, development, neurodevelopmental differences, and age-specific medical risk.
The Canadian Paediatric Society's 2024 clinical guidance recommends validation, appropriate medical assessment, clear communication, family involvement, and coordinated support for school participation. It addresses pediatric somatic symptom and related disorders broadly, so it should not be read as direct randomized evidence for every ICD-11 BDD treatment in children.
Collaborative planning may involve pediatricians, mental health clinicians, parents, and educational staff. School accommodations and reintegration should be individualized. A young person should never be punished or accused of inventing symptoms because a medical explanation is incomplete.
Discussing a diagnosis without dismissing symptoms
A good explanation starts with the actual clinical findings, the patient's priorities, and the requirements that have been met. The clinician describes what has been assessed medically and how attention, worry, activity restrictions, or other processes may contribute to suffering. Where uncertainty remains, it should be documented and followed.
Patients can reasonably ask: Which features of ICD-11 6C20 support this diagnosis? Which physical conditions were considered? How does my current medical condition affect interpretation of symptom attention? Which changes should prompt renewed investigation? Which outcomes will demonstrate that treatment is helping?
The label should not be used to characterize someone as a difficult patient, to dispute their credibility, or to halt legitimate healthcare. A respectful relationship is especially important when a person has experienced diagnostic delays or inequitable treatment.
When urgent medical assessment is necessary
New severe chest pain, significant breathing difficulty, sudden weakness or facial drooping, severe sudden headache, confusion, a first seizure-like event, loss of consciousness, major bleeding, or other rapidly evolving medical symptoms require urgent evaluation under local emergency guidance. The presence of longstanding bodily distress does not change that principle.
Existing symptoms may also evolve. Marked new deterioration, objective abnormalities, unfamiliar symptoms, or important medication adverse effects justify reassessment. Clinicians distinguish between repetitive investigations that provide little benefit and necessary evaluation of new disease or a changed clinical picture.
Practical guidance for people with persistent symptoms
Prepare a concise history describing the main symptoms, onset, major changes, diagnosed conditions, medications, relevant test results, and functional effect. A short record prepared for appointments can support communication without encouraging continuous body monitoring.
Ask the clinician to explain the medical differential, ICD-11 requirements, and reasons for particular treatment recommendations. Agree on how the team will handle new symptoms and which situations require follow-up. Where possible, work with a consistent care team that shares records and respects your goals.
If symptom monitoring, avoidance, or reassurance dominates daily life, discuss these patterns with a qualified professional as potential treatment targets. Select achievable functional goals, while honoring disability, medical activity restrictions, and the person's own preferences. Practical support for work, school, transportation, or access to care may be as important as a specific therapy.
Frequently asked questions
Is bodily distress disorder an official ICD-11 diagnosis?
Yes. It is code 6C20 within Disorders of Bodily Distress or Bodily Experience. Assessment requires the WHO clinical requirements and appropriate consideration of medical and mental health differentials.
Does BDD mean symptoms are imaginary or deliberately produced?
No. Symptoms are real experiences. The diagnosis concerns a persistent pattern of symptoms, excessive attention, and functional impact. It does not imply pretending, intentional falsification, or conscious control of pain or other symptoms.
Do all medical tests have to be normal?
No. A person can have a diagnosed physical condition and BDD. Clinicians evaluate whether attention to symptoms is clearly excessive relative to the medical condition and its severity. New relevant medical findings require appropriate assessment.
Are BDD and DSM somatic symptom disorder identical?
No. They overlap but differ in wording, emphasis, specified duration, and other clinical requirements. A 2025 population study found overlapping but nonidentical groups under operational criteria.
Is BDD the same as fibromyalgia, IBS, or chronic fatigue syndrome?
No. These conditions have their own assessment and management frameworks. Some individuals may also meet BDD criteria, but their medical diagnosis by itself is not evidence of BDD.
Is BDD another term for bodily distress syndrome?
No. Bodily distress syndrome is a separate construct used in research. Similar terminology should not obscure differences in criteria or study populations.
How does BDD differ from health anxiety?
Health anxiety concerns worry about illness. BDD requires distressing bodily symptoms with excessive attention directed toward them and meaningful impact over time. ICD-11 hypochondriasis is a separate diagnostic category.
How long must the symptoms last?
The ICD-11 description refers to a persistent pattern for several months, for example three months or longer. Duration alone cannot establish the diagnosis.
Can cognitive behavioral therapy help?
CBT has modest beneficial evidence in older somatoform and related persistent-symptom trial populations. Specific estimates for patients meeting final ICD-11 BDD criteria remain limited. Treatment is individualized.
Are stress and trauma required causes?
No. Neither stress nor a trauma history is required. Physical, emotional, cognitive, interpersonal, and environmental contributors vary across individuals, and causal claims require case-specific evidence.
Can I diagnose BDD using a symptom checklist?
No. Questionnaires can describe burden or track progress, but a full assessment includes clinical criteria, context, medical evaluation, and differential diagnoses.
Can someone recover while symptoms persist?
Yes. Greater daily participation, reduced symptom preoccupation, better coordination of care, and improved quality of life are meaningful treatment outcomes even if some sensations continue.
When should a diagnosis be reconsidered?
The clinical formulation warrants review when new warning signs appear, an established condition changes, investigations reveal relevant findings, or treatment fails to fit the presentation. Medical and mental health care can continue together.
For broader clinical context, see Somatic Symptom and Functional Disorders: Types, Diagnosis, and Treatment.
Related Articles
For historical changes in symptom-related terminology, see Neurosis vs Neurasthenia: Historical Terms, Symptoms, and Modern Classification. For the role of attention in the perception of bodily sensations, see Anxiety and Interoception: Why Body Sensations Can Become Threat Signals. For distinctions involving symptom reporting and personality-related distress, see Neuroticism and Somatic Symptoms: Symptom Reporting, Distress, and Health Context.